Two researchers from Children’s Hospital of Philadelphia (CHOP) were recently selected by the health and science news outlet STAT as 2022 Wunderkinds, an award that celebrates the next generation of scientific superstars who are making significant contributions to biomedical research.

Study on understudied non-chromosomal birth defects provides information critical to potential early detection of malignant tumors.

Patients with the identified variant may respond favorably to targeted treatment with a readily available anti-seizure medication.

CHOP experts presented six abstracts, including one abstract that won “Top Abstract,” at the Academy of Pediatric Physical Therapy Annual Conference.

A new study has found that acute myeloid leukemia (AML) ages and exhausts immune cells, impairing their ability to fight off cancer.

CHOP researchers have found that Enterococcus – an antibiotic-resistant, opportunistic pathogen – works together with C. difficile, reshaping and enhancing the metabolic environment in the gut so that C. difficile can thrive.

CHOP researchers found that a series of “liquid biopsies” could less invasively and more accurately identify tumor changes in patients with high-risk neuroblastoma.

Study found the impact was most significant on low-income adolescents, but the effect was also seen across incomes, highlighting financial stress as a youth mental health risk factor—

Researchers from Children’s Hospital of Philadelphia (CHOP) found disparities in the completion of follow-up concussion care which will help inform future research at CHOP funded by a CDC grant that specifically aims to address such disparities.

Researchers from Children’s Hospital of Philadelphia (CHOP) have found that economically disadvantaged children treated with CAR T-cell therapy for relapsed/refractory acute lymphoblastic leukemia (ALL) fair just as well as children from more socioeconomically advantaged backgrounds.